Western Region Islet Study Group

西域岛研究小组

基本信息

  • 批准号:
    7282498
  • 负责人:
  • 金额:
    $ 0.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-20 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In the past few years, the NIH has placed increasing emphasis on improving our understanding of beta-cell biology as a necessary step towards developing a definitive therapy for diabetes. In particular, NIDDK is promoting collaborative inter-institutional efforts in this area as evidenced by the upcoming formation of a national beta-cell consortium. To further facilitate progress and cooperation in the area of beta-cell biology, the idea of starting a Western Region Islet Study Group (WRISG) was proposed in the summer of 2000 to bring together 60-100 participants at an annual meeting to meet and exchange ideas. A strong emphasis on the participation of young investigators at the graduate and postgraduate level was proposed. An organizing committee was chosen of established researchers in basic islet and diabetes research from 6 geographically dispersed centers namely Denver, Los Angeles, Portland, San Diego, San Francisco, Seattle and Vancouver, and a membership database compiled centrally. The inaugural meeting of the group was held September 28th - 30 th 2001 at the Marconi conference center near San Francisco and was attended by 72 islet researchers from the western U.S. and Canada. The second meeting was held at the Victoria Conference Center in Victoria B.C. from Nov 1-3rd, 2002 and was attended by 86 researchers. Both meetings were a remarkable success, and provided an excellent program of presentations primarily by students and fellows as well as ample time for interaction among, attendees. The 3rd annual meeting of the Western Region Islet Study group is planned for September 19th - September 21st, 2003 at the Bell Harbor Conference Center in Seattle, Washington. We anticipate a continuing increase in participation as evidenced by the first two meetings. As with our last meeting, six topic areas will be covered:  Embryological development of the endocrine pancreas.  Postnatal islet development - ductal cells, progenitor cells, islet neogenesis.  Islet beta cell survival and apoptosis.  Regulation of proinsulin synthesis and insulin secretion.  Islet cell biology - granule biogenesis, granule transport, exocytosis, islet cell contact.  The islet in type-1 & -2 diabetes - pathology and novel therapeutic approaches. The meeting will center around 6 scientific sessions of 2 hours covering the above topic areas. Oral presentations of 20-minute duration will be delivered from abstract submissions reviewed and selected by the organizing committee (see below). A strong bias will be made towards young investigators in the selection process but consideration will be also given to favor women, underrepresented minorities and individuals with disabilities. Outside of the main program there will be one invited lecture and informal discussion groups. Facilities will be provided for job seminars if requested and a bulletin board for positions vacant and wanted will be displayed. The primary goal of the meeting is to bring together as many of the young investigators in the islet research field within the region and to foster communication and collaboration between these individuals and their supporting group. The meeting will be more than just a conference focused on a topical area of great scientific and social importance. It will be an important step in catalyzing further development in the field and unifying researchers for the task ahead: to involve the next generation of research consortia and strong liaison between academia and industry.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN C HUTTON其他文献

JOHN C HUTTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN C HUTTON', 18)}}的其他基金

Novel islet autoantibodies in diabetes
糖尿病中的新型胰岛自身抗体
  • 批准号:
    8311938
  • 财政年份:
    2011
  • 资助金额:
    $ 0.24万
  • 项目类别:
Sector Imager 6000 Plate Reader
Sector Imager 6000 读板器
  • 批准号:
    8050230
  • 财政年份:
    2011
  • 资助金额:
    $ 0.24万
  • 项目类别:
P&F
  • 批准号:
    7658010
  • 财政年份:
    2006
  • 资助金额:
    $ 0.24万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7658006
  • 财政年份:
    2006
  • 资助金额:
    $ 0.24万
  • 项目类别:
ABI Genetic Analyzer-DNA Sequencer 3100
ABI基因分析仪-DNA测序仪3100
  • 批准号:
    6440380
  • 财政年份:
    2002
  • 资助金额:
    $ 0.24万
  • 项目类别:
Western Region Islet Study Group
西域岛研究小组
  • 批准号:
    6557477
  • 财政年份:
    2002
  • 资助金额:
    $ 0.24万
  • 项目类别:
Development and Regeneration of the Endocrine Pancreas
内分泌胰腺的发育和再生
  • 批准号:
    6926044
  • 财政年份:
    2001
  • 资助金额:
    $ 0.24万
  • 项目类别:
Vesicular traffic and regulated secretion in C. elegans
线虫中的囊泡运输和调节分泌
  • 批准号:
    6440376
  • 财政年份:
    2001
  • 资助金额:
    $ 0.24万
  • 项目类别:
Development and Regeneration of the Endocrine Pancreas
内分泌胰腺的发育和再生
  • 批准号:
    6799383
  • 财政年份:
    2001
  • 资助金额:
    $ 0.24万
  • 项目类别:
Western Region Islet Study Group
西域岛研究小组
  • 批准号:
    6419975
  • 财政年份:
    2001
  • 资助金额:
    $ 0.24万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 0.24万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 0.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 0.24万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 0.24万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了